{"id":534809,"date":"2021-09-07T08:08:24","date_gmt":"2021-09-07T12:08:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/"},"modified":"2021-09-07T08:08:24","modified_gmt":"2021-09-07T12:08:24","slug":"savara-to-participate-in-two-upcoming-investor-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/","title":{"rendered":"Savara to Participate in Two Upcoming Investor Healthcare Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Savara to Participate in Two Upcoming Investor Healthcare Conferences<\/b><\/p>\n<p class=\"bwalignc\"><i>H.C. Wainwright 23rd Annual Global Investment Conference<\/i><\/p>\n<p class=\"bwalignc\"><i>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit<\/i><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.savarapharma.com%2F&amp;esheet=52486754&amp;newsitemid=20210907005242&amp;lan=en-US&amp;anchor=Savara+Inc.&amp;index=1&amp;md5=a538305a1fa42bec51df6f8b6f99d920\">Savara Inc.<\/a> (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nH.C. Wainwright 23rd Annual Global Investment Conference: A pre-recorded webcast of the presentation will be available beginning at 7:00 AM ET \/ 4:00 AM PT on September 13, 2021.\n<\/li>\n<li>\nOppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit: A live webcast of the presentation will take place at 12:25 PM ET \/ 9:25 AM PT on September 20, 2021.\n<\/li>\n<\/ul>\n<p>\nBoth webcast presentations will be available through the Investors page of Savara\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.savarapharma.com%2Finvestors%2Fevents-presentations%2F&amp;esheet=52486754&amp;newsitemid=20210907005242&amp;lan=en-US&amp;anchor=www.savarapharma.com%2Finvestors%2Fevents-presentations%2F&amp;index=2&amp;md5=f173fec52ae83cb31ef7c628ff7f9715\">www.savarapharma.com\/investors\/events-presentations\/<\/a> and will be archived for 90 days.\n<\/p>\n<p><b>About Savara<\/b><\/p>\n<p>\nSavara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow<sup>\u00ae<\/sup> Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.\n<\/p>\n<p>\nMore information can be found at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsavarapharma.com%2F&amp;esheet=52486754&amp;newsitemid=20210907005242&amp;lan=en-US&amp;anchor=https%3A%2F%2Fsavarapharma.com%2F&amp;index=3&amp;md5=da93a2258bd345fa7550c9d9742fd805\">https:\/\/savarapharma.com\/<\/a>. (Twitter: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FSavaraPharma%3Flang%3Den&amp;esheet=52486754&amp;newsitemid=20210907005242&amp;lan=en-US&amp;anchor=%40SavaraPharma&amp;index=4&amp;md5=b5469c42059b13350b65f47f51156263\">@SavaraPharma<\/a>, LinkedIn: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsavara-pharmaceuticals%2F&amp;esheet=52486754&amp;newsitemid=20210907005242&amp;lan=en-US&amp;anchor=www.linkedin.com%2Fcompany%2Fsavara-pharmaceuticals%2F&amp;index=5&amp;md5=d4a3477e11390df1a323e1a1fd59c40f\">www.linkedin.com\/company\/savara-pharmaceuticals\/<\/a>).\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210907005242\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210907005242\/en\/<\/a><\/span><\/p>\n<p><b>Savara Inc. IR &amp; PR<br \/>\n<\/b><br \/>Anne Erickson (<a rel=\"nofollow\" href=\"mailto:anne.erickson@savarapharma.com\">anne.erickson@savarapharma.com<\/a>)<br \/>\n<br \/>(512) 851-1366\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210907005242\/en\/747459\/3\/SavaraLogo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Savara to Participate in Two Upcoming Investor Healthcare Conferences H.C. Wainwright 23rd Annual Global Investment Conference Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences: H.C. Wainwright 23rd Annual Global Investment Conference: A pre-recorded webcast of the presentation will be available beginning at 7:00 AM ET \/ 4:00 AM PT on September 13, 2021. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit: A live webcast of the presentation will take place at 12:25 PM ET \/ 9:25 AM PT on September 20, 2021. Both webcast presentations will be available through the Investors &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Savara to Participate in Two Upcoming Investor Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534809","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Savara to Participate in Two Upcoming Investor Healthcare Conferences H.C. Wainwright 23rd Annual Global Investment Conference Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences: H.C. Wainwright 23rd Annual Global Investment Conference: A pre-recorded webcast of the presentation will be available beginning at 7:00 AM ET \/ 4:00 AM PT on September 13, 2021. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit: A live webcast of the presentation will take place at 12:25 PM ET \/ 9:25 AM PT on September 20, 2021. Both webcast presentations will be available through the Investors &hellip; Continue reading &quot;Savara to Participate in Two Upcoming Investor Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Savara to Participate in Two Upcoming Investor Healthcare Conferences\",\"datePublished\":\"2021-09-07T12:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/\"},\"wordCount\":270,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/\",\"name\":\"Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-07T12:08:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Savara to Participate in Two Upcoming Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk","og_description":"Savara to Participate in Two Upcoming Investor Healthcare Conferences H.C. Wainwright 23rd Annual Global Investment Conference Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences: H.C. Wainwright 23rd Annual Global Investment Conference: A pre-recorded webcast of the presentation will be available beginning at 7:00 AM ET \/ 4:00 AM PT on September 13, 2021. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit: A live webcast of the presentation will take place at 12:25 PM ET \/ 9:25 AM PT on September 20, 2021. Both webcast presentations will be available through the Investors &hellip; Continue reading \"Savara to Participate in Two Upcoming Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:08:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Savara to Participate in Two Upcoming Investor Healthcare Conferences","datePublished":"2021-09-07T12:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/"},"wordCount":270,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/","name":"Savara to Participate in Two Upcoming Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-07T12:08:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-to-participate-in-two-upcoming-investor-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Savara to Participate in Two Upcoming Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534809"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534809\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}